OUTCOME OF PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION (STEMI) BASED ON ADMISSION SERUM POTASSIUM LEVEL.
Sidra Qayyum Malik1, Fatima Qayyum2, Masud Akhtar Malik2
1Benazir Bhutto Teaching hospital, Abbottabad-Pakistan.
Journal of Ayub Medical College, Abbottabad : JAMC
|December 3, 2024
Summary
In acute ST-elevation myocardial infarction (STEMI) patients, admission serum potassium levels did not predict in-hospital mortality. Advanced age, however, was significantly associated with a higher risk of death.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Potassium levels (hypokalemia and hyperkalemia) significantly impact cardiovascular patient mortality.
- Understanding the role of serum potassium in acute ST-elevation myocardial infarction (STEMI) is crucial for patient outcomes.
Purpose of the Study:
- To investigate the correlation between admission serum potassium levels and in-hospital mortality in STEMI patients.
- To identify predictors of short-term mortality in STEMI patients.
Main Methods:
- A study involving 225 STEMI patients treated with streptokinase at Ayub Teaching Hospital, Abbottabad.
- Serum potassium levels were measured at admission and correlated with in-hospital survival within 72 hours.
Main Results:
- The mean admission serum potassium level was 4.2 mmol/dL, with 74.2% of patients discharged alive.
- While older age was linked to increased mortality risk, serum potassium levels, gender, systolic blood pressure, and heart rate showed no significant association with outcomes.
- Logistic regression confirmed age as a significant predictor of mortality.
Conclusions:
- Admission serum potassium levels did not demonstrate significant predictive value for mortality in STEMI patients.
- Advanced age emerged as a significant factor influencing mortality in this patient cohort.
- Further research is recommended to understand the complex factors affecting STEMI patient mortality and improve management.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:26Exercise Stress Test
Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...